<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37173355</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19.</ArticleTitle><Pagination><StartPage>7717</StartPage><MedlinePgn>7717</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-34678-8</ELocationID><Abstract><AbstractText>A growing number of patients with SARS-CoV-2 infections experience long-lasting symptoms. Even patients who suffered from a mild acute infection show a variety of persisting and debilitating neurocognitive, respiratory, or cardiac symptoms (Long-Covid syndrome), consequently leading to limitations in everyday life. Because data on health-related quality of life (HRQoL) is scarce, we aimed to characterize the impact of Long-Covid symptoms after a mild or moderate acute infection on HRQoL. In this observational study, outpatients seeking counseling in the interdisciplinary Post-Covid consultation of the University Hospital Zurich with symptoms persisting for more than 4&#xa0;weeks were included. Patients who received an alternative diagnosis or suffered from a severe acute Covid-19 infection were excluded. St. George's Respiratory Questionnaire (SGRQ), Euroquol-5D-5L (EQ-5D-5L), and the Short form 36 (SF-36) were distributed to assess HRQoL. 112 patients were included, 86 (76.8%) were female, median (IQR) age was 43 (32.0, 52.5) years with 126 (91, 180) days of symptoms. Patients suffered frequently from fatigue (81%), concentration difficulties (60%), and dyspnea (60%). Patients mostly stated impairment in performing usual activities and having pain/discomfort or anxiety out of the EQ-5D-5L. EQ index value and SGRQ activity score component were significantly lower in females. SF-36 scores showed remarkably lower scores in the physical health domain compared to the Swiss general population before and during the COVID-19 pandemic. Long-Covid syndrome has a substantial impact on HRQoL. Long-term surveillance of patients must provide clarity on the duration of impairments in physical and mental health.Trial registration: The study is registered on www.ClinicalTrials.gov , NCT04793269.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malesevic</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland. stefan.malesevic@usz.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland. stefan.malesevic@usz.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sievi</LastName><ForeName>Noriane A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumgartner</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roser</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommer</LastName><ForeName>Grit</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Research, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>D&#xf6;rthe</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallelian</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jelcic</LastName><ForeName>Ilijas</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarenbach</LastName><ForeName>Christian F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04793269</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37173355</ArticleId><ArticleId IdType="pmc">PMC10175927</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-34678-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-34678-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2021, 11 October Available from: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Bundesamt f&#xfc;r Gesundheit BAG. Covid-19 Schweiz Situationsbericht 2021, October 08 Available from: https://www.covid19.admin.ch/de/overview.</Citation></Reference><Reference><Citation>Wu, Z., McGoogan, J. M. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 323(13). 10.1001/jama.2020.2648 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. Six-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet397(10270). 10.1016/S0140-6736(20)32656-8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38. 10.1016/j.eclinm.2021.101019 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie, T., Hittle, M., Goodman, S. N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw. Open. 4(5). 10.1001/jamanetworkopen.2021.11417 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes, D. L., Holdsworth, L., Jawad, N., Gunasekera, P., Morice, A. H., Crooks, M. G. Post-COVID-19 Symptom Burden: what is long-COVID and how should we manage it? Lung 199(2). 10.1007/s00408-021-00423-z (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis, R. H., Green, J., Santillana, M., Lazer, D., Ognyanova, K., Simonson, M., et al. Persistence of symptoms up to 10 months following acute COVID-19 illness. medRxiv. 10.1101/2021.03.07.21253072 (2021).</Citation></Reference><Reference><Citation>Carmo, A., Pereira-Vaz, J., Mota, V., Mendes, A., Morais, C., da Silva, A. C., et al. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J Med Virol. 92(10). 10.1002/jmv.26103 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301002</ArticleId><ArticleId IdType="pubmed">32484958</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Q., Zheng, X. S., Shen, X. R., Si, H. R., Wang, X., Wang, Q., et al. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg. Microbes Infect. 9(1). 10.1080/22221751.2020.1852058 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734137</ArticleId><ArticleId IdType="pubmed">33196399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y., Guo, C., Tang, L., Hong, Z., Zhou, J., Dong, X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol.5(5). 10.1016/S2468-1253(20)30083-2 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson, A. C., Humbert, M., Buggert, M. The known unknowns of T cell immunity to COVID-19. Sci. Immunol.5(53). 10.1126/sciimmunol.abe8063 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33208380</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi, O. L., Hughes, S. E., Turner, G., Rivera, S. C., McMullan, C., Chandan, J. S., et al. Symptoms, complications and management of long COVID: a review. J. R. Soc. Med.114(9). 10.1177/01410768211032850 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai, J. C., Ko, F. W., Ng, S. S., To, K. W., Tong, M., Hui, D. S. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology 15(3). 10.1111/j.1440-1843.2010.01720.x (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7(7). 10.1016/S2215-0366(20)30203-0 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa, S., Nora-Krukle, Z., Henning, N., Eliassen, E., Shikova, E., Harrer, T., et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med. 16(1). 10.1186/s12967-018-1644-y (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med.41(10). 10.1016/0277-9536(95)00112-k (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8560308</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstrom, K., Johannesson, M., Diderichsen, F. Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy. 55(1). 10.1016/s0168-8510(00)00111-1 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11137188</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, L., Moran, G. M., Roberts, L. M., Calvert, M., McCahon, D. The burden of common chronic disease on health-related quality of life in an elderly community-dwelling population in the UK. Fam. Pract.31(5). 10.1093/fampra/cmu035 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24987022</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyworth, I. T., Hazell, M. L., Linehan, M. F., Frank, T. L. How do common chronic conditions affect health-related quality of life? Br. J. Gen. Pract.59(568). 10.3399/bjgp09X453990 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2765853</ArticleId><ArticleId IdType="pubmed">19656444</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari Sari A, Karimi F, Emrani Z, Zeraati H, Olyaeemanesh A, Daroudi R. The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L. Cost Effect. Resour. Alloc.19(1). 10.1186/s12962-021-00282-8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117596</ArticleId><ArticleId IdType="pubmed">33985522</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu G, Zhen Q, Wang W, Fan S, Wu Q, Zhang C, et al. Health-related quality of life of COVID-19 patients after discharge: a multicenter follow-up study. J. Clin. Nurs.30(11&#x2013;12). 10.1111/jocn.15733 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013595</ArticleId><ArticleId IdType="pubmed">33656210</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit, D., O'Hara, M. E., Akrami, A., Perego, E., Olliaro, P., Needham, D. M. Long COVID: aiming for a consensus. Lancet Respir. Med. 10(7). 10.1016/S2213-2600(22)00135-7. (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Living guidance for clinical management of COVID-19 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/349321/WHO-2019-nCoV-clinical-2021.2-eng.pdf.</Citation></Reference><Reference><Citation>Jones, P. W. Quality of life measurement for patients with diseases of the airways. Thorax46(9). 10.1136/thx.46.9.676 (1991).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC463372</ArticleId><ArticleId IdType="pubmed">1835178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, P. W., Quirk, F. H., Baveystock, C. M..The St George's Respiratory Questionnaire. Respir. Med.85 Suppl B. 10.1016/s0954-6111(06)80166-6 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1759018</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, P. W. St. George's Respiratory questionnaire manual 2009. Available from: https://meetinstrumentenzorg.nl/wp-content/uploads/instrumenten/SGRQ-handl-Eng.pdf.</Citation></Reference><Reference><Citation>EuroQol, G. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 16(3). 10.1016/0168-8510(90)90421-9 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305(6846). 10.1136/bmj.305.6846.160 (1992).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1883187</ArticleId><ArticleId IdType="pubmed">1285753</ArticleId></ArticleIdList></Reference><Reference><Citation>Laucis, N. C., Hays, R. D., Bhattacharyya, T. Scoring the SF-36 in orthopaedics: a brief guide. J. Bone Jt. Surg. Am.97(19). 10.2106/jbjs.O.00030 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5029523</ArticleId><ArticleId IdType="pubmed">26446970</ArticleId></ArticleIdList></Reference><Reference><Citation>Roser, K., Mader, L., Baenziger, J., Sommer, G., Kuehni, C. E., Michel, G. Health-related quality of life in Switzerland: normative data for the SF-36v2 questionnaire. Qual. Life Res.28(7). 10.1007/s11136-019-02161-5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6571102</ArticleId><ArticleId IdType="pubmed">30848444</ArticleId></ArticleIdList></Reference><Reference><Citation>Taft, C., Karlsson, J., Sullivan, M. Do SF-36 summary component scores accurately summarize subscale scores? Qual. Life Res.10(5). 10.1023/a:1012552211996 (2001)</Citation><ArticleIdList><ArticleId IdType="pubmed">11763202</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham, E. L., Clark, J. R., Orban, Z. S., Lim, P. H., Szymanski, A. L., Taylor, C., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann. Clin. Transl. Neurol.8(5). 10.1002/acn3.51350 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell, M. L., Catalfamo, C. J., Farland, L. V., Ernst, K. C., Jacobs, E. T., Klimentidis, Y. C., et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 16(8). 10.1371/journal.pone.0254347 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardone, A., Sorrentino, P., Giancamilli, F., Palombi, T., Simper, T., Mandolesi, L., et al. Psychosocial variables and quality of life during the COVID-19 lockdown: a correlational study on a convenience sample of young Italians. PeerJ. 8. 10.7717/peerj.10611 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751426</ArticleId><ArticleId IdType="pubmed">33384910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Ma, Z. F. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: a cross-sectional study. Int. J. Environ. Res. Public Health. 17(7). 10.3390/ijerph17072381 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177660</ArticleId><ArticleId IdType="pubmed">32244498</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell, S., Trott, M., Tully, M., Shin, J., Barnett, Y., Butler, L., et al. Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review. BMJ Open Sport Exerc. Med.7(1). 10.1136/bmjsem-2020-000960 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852071</ArticleId><ArticleId IdType="pubmed">34192010</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepin, J. L., Bruno, R. M., Yang, R. Y., Vercamer, V., Jouhaud, P., Escourrou, P., et al. Wearable activity trackers for monitoring adherence to home confinement during the COVID-19 pandemic worldwide: data aggregation and analysis. J. Med. Internet Res. 22(6). 10.2196/19787 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307323</ArticleId><ArticleId IdType="pubmed">32501803</ArticleId></ArticleIdList></Reference><Reference><Citation>Frendl, D. M., Ware, J. E. J. Patient-reported functional health and well-being outcomes with drug therapy: A systematic review of randomized trials using the SF-36 health survey. Medical Care52(5). 10.1097/mlr.000000000000010311 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24714581</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, D. T., Hamilton, F. W., Milne, A., Morley, A. J., Viner, J., Attwood, M., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax76(4). 10.1136/thoraxjnl-2020-216086 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Salaffi, F., Sarzi-Puttini, P., Girolimetti, R., Atzeni, F., Gasparini, S., Grassi, W. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin. Exp. Rheumatol. 27(5 Suppl 56) (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20074443</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber, A., Oldridge, N., H&#xf6;fer, S. International SF-36 reference values in patients with ischemic heart disease. Qual. Life Res.25(11). 10.1007/s11136-016-1316-4 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065592</ArticleId><ArticleId IdType="pubmed">27318487</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott, T. E., Renier, C. M., Palcher, J. A. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 4(4). 10.1111/j.1526-4637.2003.03040.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">14750909</ArticleId></ArticleIdList></Reference><Reference><Citation>Betschart, M., Rezek, S., Unger, I., Ott, N., Beyer, S., B&#xf6;ni, A., et al. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study. Swiss Med. Wkly. 151. 10.4414/smw.2021.w30072.</Citation><ArticleIdList><ArticleId IdType="pubmed">34751538</ArticleId></ArticleIdList></Reference><Reference><Citation>Meys, R., Delbressine, J. M., Go&#xeb;rtz, Y. M. J., Vaes, A. W., Machado, F. V. C., Van Herck, M., et al. Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. J. Clin. Med.9(12). 10.3390/jcm9123993 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764406</ArticleId><ArticleId IdType="pubmed">33317214</ArticleId></ArticleIdList></Reference><Reference><Citation>Todt, B. C., Szlejf, C., Duim, E., Linhares, A. O. M., Kogiso, D., Varela, G., et al. Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge. Respir. Med. 184. 10.1016/j.rmed.2021.106453 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116128</ArticleId><ArticleId IdType="pubmed">34010740</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada, M., Moreno, E., Cari&#xf1;ena, A., Rey, T., Pita-Romero, R., Leal, S., et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br. J. Anaesth.126(3). 10.1016/j.bja.2020.12.007 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, P. W., Brusselle, G., Dal Negro, R. W., Ferrer, M., Kardos, P., Levy, M. L., et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir. Med. 105(1). 10.1016/j.rmed.2010.09.004 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">20932736</ArticleId></ArticleIdList></Reference><Reference><Citation>Matudm, M. Gender differences in stress and coping styles. Personality Individual Differ. 37 (2004).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>